Evidence map›Paper›PMID 10414992›Full record

ArticleThe Journal of neuroscience : the official journal of the Society for Neuroscience1999

Pituitary adenylate cyclase activating peptide phase shifts circadian rhythms in a manner similar to light.

M E Harrington, S Hoque, A Hall, D Golombek, S Biello

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of neuroscience : the official journal of the Society for Neuroscience, 1999. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 40 papers.

0numbers the graph read from it
0cells of the map it votes in
40citing papers in PubMed
4.9field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

40 citing papers in PubMed, 152 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Circulating PACAP peptide and PAC1R genotype as possible transdiagnostic biomarkers for anxiety disorders in women: a preliminary study.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2020
    Article
  6. Review
  7. Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Circadian Regulation of Glutamate Transporters.Frontiers in endocrinology · 2018
    Review
  13. Article
  14. The sleep-promoting and hypothermic effects of glycine are mediated by NMDA receptors in the suprachiasmatic nucleus.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2015
    Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Circadian entrainment and its role in depression: a mechanistic review.Journal of neural transmission (Vienna, Austria : 1996) · 2012
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 4 institutions in 3 countries.

M E HarringtonDepartments of Psychology and Biological Sciences, Smith College, Northampton, Massachusetts 01063, USA.
S Hoque
A Hall
D Golombek
S Biello
Smith College · USMount Holyoke College · USUniversity of Buenos Aires · ARUniversity of Glasgow · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The endogenous circadian pacemaker in mammals is located in the suprachiasmatic nuclei (SCN) of the hypothalamus. Various cues can reset circadian rhythm phase, thereby entraining the internal rhythm to the environmental cycle, and these effects can be investigated using an in vitro method to measure phase shifts of the SCN. Although pituitary adenylate cyclase activating peptide (PACAP) is localized in retinal inputs to the SCN, it has been reported to alter clock phase only during the subjective day (Hannibal et al., 1997), whereas light alters phase only in the subjective night. In this study we show that PACAP can reset the clock in the photic pattern during the subjective night when applied in 10 pM to 1 nM doses. This appears to be mediated via a glutamatergic mechanism, possibly by potentiation of NMDA currents as is seen at 10-100 pM. Given at higher doses (>10 nM), PACAP shifts in the subjective day, apparently via activation of adenylate cyclase and increased intracellular cAMP. These results indicate dose and phase specificity of the effects of PACAP, and a new role as a transmitter in the retinohypothalamic tract.

Indexed as

LightAnimalsCircadian RhythmCricetinaeDose-Response Relationship, DrugDrug CombinationsElectrophysiologyGlycineMaleMesocricetusNeuronsNeuropeptidesN-MethylaspartatePituitary Adenylate Cyclase-Activating PolypeptideReceptors, N-Methyl-D-AspartateSuprachiasmatic NucleusDrug CombinationsGlycineNeuropeptidesN-MethylaspartatePituitary Adenylate Cyclase-Activating PolypeptideReceptors, N-Methyl-D-Aspartate

Identifiers

PMID10414992
PMCPMC6782812
OpenAlexW1757207483

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.